(Q34135741)

31 July 2017

title

Viral hit and run-oncogenesis: genetic and epigenetic scenarios (English)

1 reference

31 July 2017

Viral hit and run-oncogenesis: Genetic and epigenetic scenarios (English)

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

5 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20813452

5 July 2024

author name string

Hans Helmut Niller

1

1 reference

31 July 2017

Hans Wolf

2

1 reference

31 July 2017

Janos Minarovits

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

31 July 2017

28 June 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20813452

full work available at URL

5 July 2024

https://api.elsevier.com/content/article/PII:S0304383510003885?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

https://api.elsevier.com/content/article/PII:S0304383510003885?httpAccept=text/plain

5 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

5 July 2024

1 reference

31 July 2017

volume

305

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

200-217

1 reference

EBV promotes human CD8 NKT cell development

31 July 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PPAT.1000915

The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Alterations in the cellular phenotype induced by herpes simplex viruses

5 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Transformation of rodent fibroblasts by herpes simplex virus: Presence of morphological transforming region 1 (MTR 1) is not required for the maintenance of the transformed state

5 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Transformation of NIH 3T3 cells with cloned fragments of human cytomegalovirus strain AD169

5 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Neoplastic transformation by a cloned human cytomegalovirus DNA fragment uniquely homologous to one of the transforming regions of herpes simplex virus type 2

5 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

‘Hit and run’ oncogenesis by human papillomavirus type 18 DNA

5 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins

5 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Combined herpes simplex virus type 2 and human papillomavirus type 16 or 18 deoxyribonucleic acid leads to oncogenic transformation

5 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes

5 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Plasmid-induced "hit-and-run" tumorigenesis in Chinese hamster embryo fibroblast (CHEF) cells

5 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

5 July 2024

Viruses in human cancers

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Infectious agents and cancer: criteria for a causal relation

5 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

HBV induced carcinogenesis

5 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis B virus induced hepatocellular carcinoma

5 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hit-and-run mechanism of HBV-mediated progression to hepatocellular carcinoma.

5 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Noncytolytic control of viral infections by the innate and adaptive immune response

5 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

T cell response in hepatitis C virus infection

5 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis

5 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway

5 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation.

5 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

5 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA

5 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review

5 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells

5 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

5 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling

5 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations.

5 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes

5 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy

5 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

5 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

5 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa

5 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

5 July 2024

Viruses and lymphomas

35

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus

5 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Human polyomaviruses and cancer: expanding repertoire

5 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The role of polyomaviruses in human disease

5 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Identification of a third human polyomavirus

5 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Identification of a novel polyomavirus from patients with acute respiratory tract infections

5 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma

5 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Clonal integration of a polyomavirus in human Merkel cell carcinoma

5 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus

5 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals.

5 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients

5 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Novel human polyomaviruses--re-emergence of a well known virus family as possible human carcinogens

5 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma

5 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?

5 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Potential mechanisms of the human polyomavirus JC in neural oncogenesis

5 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Human neurotropic polyomavirus, JCV, and its role in carcinogenesis

5 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma.

5 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Glioblastoma multiforme with small cell neuronal-like component: association with human neurotropic JC virus

5 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Oncogenic transformation by BK virus and association with human tumors.

5 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

BK virus and human cancer: innocent until proven guilty

5 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Adenovirus early E4 genes in viral oncogenesis

5 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Integrated viral genomes can be lost from adenovirus type 12-induced hamster tumor cells in a clone-specific, multistep process with retention of the oncogenic phenotype

5 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

"Hit-and-run" transformation by adenovirus oncogenes

5 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation

5 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex

5 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex

5 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner

5 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus and cancer

5 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

5 July 2024

Epstein–Barr virus

67

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus-associated epithelial and mesenchymal neoplasms

5 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases

5 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Spectrum of Epstein-Barr virus-related diseases: a pictorial review

5 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia

5 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Immortalization of monkey epithelial cells by specific fragments of Epstein–Barr virus DNA

5 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

5 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

5 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Final case reporting from the ugandan prospective study of the relationship between ebv and burktit's lymphoma

5 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

5 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma

5 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China

5 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus with heterogeneous DNA disrupts latency

5 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo

5 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia

5 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma

5 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain

5 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.

5 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells

5 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.

5 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses

5 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Linear association between cellular DNA and Epstein-Barr virus DNA in a human lymphoblastoid cell line

5 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Intracellular forms of Epstein–Barr virus DNA in human tumour cells in vivo

5 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-barr virus integration in human lymphomas and lymphoid cell lines

5 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line

5 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site

5 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line

5 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma

5 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

EBV-associated neoplasms: alternative pathogenetic pathways

5 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The LCR of EBV makes Burkitt's lymphoma endemic

5 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus

5 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Chromatin profiling of Epstein-Barr virus latency control region

5 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity

5 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study

5 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hodgkin's disease in patients with previous infectious mononucleosis

5 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

5 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus in Hodgkin's disease and site of origin of tumour

5 July 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-barr virus, fatal infectious mononucleosis, and Hodgkin's disease in siblings

5 July 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma

5 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

5 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma

5 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

5 July 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection

5 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

5 July 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults.

5 July 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease

5 July 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis

5 July 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease

5 July 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated.

5 July 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation

5 July 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease

5 July 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Breast cancer and microbial cancer incidence in female populations around the world: a surprising hyperbolic association.

5 July 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epidemiology of hodgkin's disease in the young

5 July 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Is breast cancer caused by late exposure to a common virus?

5 July 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Observation of cells resembling Sternberg-Reed cells in conditions other than Hodgkin's disease

5 July 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)

5 July 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer

5 July 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Detection of Epstein-Barr virus in invasive breast cancers.

5 July 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation

5 July 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

EB viral genomes in epithelial nasopharyngeal carcinoma cells

5 July 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Nasopharyngeal carcinoma. X. Presence of Epstein-Barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya

5 July 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Focus on nasopharyngeal carcinoma

5 July 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ

5 July 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.

5 July 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

5 July 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives

5 July 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential

5 July 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus in the pathogenesis of NPC.

5 July 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas

5 July 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Functional delivery of viral miRNAs via exosomes

5 July 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

5 July 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma

5 July 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity

5 July 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis

5 July 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

EBV gene expression in an NPC-related tumour.

5 July 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer

5 July 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Establishment of immortalized primate epithelial cells with sub-genomic EBV DNA.

5 July 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?

5 July 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus

5 July 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

5 July 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells

5 July 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a "ping-pong evolution" model for persisting viruses and their hosts. A review

5 July 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

5 July 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

5 July 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

5 July 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease

5 July 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

LR1 regulates c-myc transcription in B-cell lymphomas

5 July 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA

5 July 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye

5 July 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator

5 July 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations

5 July 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells

5 July 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Enhancement of genetic instability in human B cells by Epstein-Barr virus latent infection

5 July 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.

5 July 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.

5 July 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching

5 July 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth.

5 July 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma

5 July 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction

5 July 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The intersection of Epstein-Barr virus with the germinal center

5 July 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number

5 July 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

5 July 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2

5 July 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes.

5 July 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Peripheral blood lymphocytes express recombination-activating genes 1 and 2 during Epstein-Barr virus-induced infectious mononucleosis

5 July 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The DDE recombinases: diverse roles in acquired and innate immunity

5 July 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Paleo-immunology: evidence consistent with insertion of a primordial herpes virus-like element in the origins of acquired immunity

5 July 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Expression of the recombination-activating genes in extrafollicular lymphocytes but no apparent reinduction in germinal center reactions in human tonsils

5 July 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines

5 July 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA.

5 July 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments

5 July 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines

5 July 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Illegitimate transcription: transcription of any gene in any cell type

5 July 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells

5 July 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.

5 July 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Immunoglobulin G expression in carcinomas and cancer cell lines

5 July 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines

5 July 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Upregulated expression of kappa light chain by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-kappaB and AP-1 pathways

5 July 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Translating the Histone Code

5 July 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

DNA methylation patterns and epigenetic memory

5 July 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation

5 July 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epigenome programming by Polycomb and Trithorax proteins.

5 July 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The multidomain protein Brpf1 binds histones and is required for Hox gene expression and segmental identity

5 July 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epigenetic field for cancerization

5 July 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Excavating relics of DNA methylation changes during the development of neoplasia

5 July 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer

5 July 2024

216

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma

5 July 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma

5 July 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis

5 July 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling

5 July 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Subnuclear trafficking and gene targeting by steroid receptors

5 July 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex

5 July 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway

5 July 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein

5 July 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Isolation of NotI clusters hypomethylated in HBV-integrated hepatocellular carcinomas by two-dimensional electrophoresis

5 July 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b.

5 July 2024

226

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells

5 July 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

5 July 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.

5 July 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection

5 July 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins

5 July 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Life and death decisions by the E2F transcription factors

5 July 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway

5 July 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway

5 July 2024

234

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Viral oncoproteins target the DNA methyltransferases

5 July 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Chromatin at the intersection of viral infection and DNA damage

5 July 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Chromosomal insertion of foreign (adenovirus type 12, plasmid, or bacteriophage lambda) DNA is associated with enhanced methylation of cellular DNA segments

5 July 2024

237

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epigenetic mechanisms in human adenovirus type 12 oncogenesis

5 July 2024

238

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen

5 July 2024

239

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Studying development of disease through temporally controlled gene expression in the salivary gland

5 July 2024

240

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras.

5 July 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication

5 July 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases

5 July 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling

5 July 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA

5 July 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor

5 July 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The HTLV-1 Tax interactome

5 July 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

The retroviral oncoprotein Tax targets the coiled-coil centrosomal protein TAX1BP2 to induce centrosome overduplication

5 July 2024

249

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

DNA aneuploidy of adult T-cell leukemia cells

5 July 2024

250

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)

5 July 2024

251

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells

5 July 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.007

5 July 2024

Identifiers

1 reference

31 July 2017

1 reference